“…This led us to query other known Th17 inhibitors induced under CD28 costimulation conditions, and indeed, Gfi1, oncostatin M, and SOCS3 were increased along with Foxp3, CTLA4, and LAG3 (Chang et al, 2009; Kurebayashi et al, 2012; Qin et al, 2009; Son et al, 2017; Zhu et al, 2009; Figures 2A and 2E–2H). Differential expression of AP-1 transcription family members has been found to modulate Th17 development (Bauquet et al, 2009; Carr et al, 2017; Ciofani et al, 2012; Schraml et al, 2009), and accordingly, JUN, JUND, FOS, and FOSL2 were increased following CD28 costimulation, whereas Th17 CD28null cells expressed relatively higher levels of Th17-promoting BATF and MAF (Figures 2A, 2I, and 2J), indicating that CD28 signaling altered the balance of expression of AP-1 family members to disfavor Th17 development. Taken together, these data support our conclusion that IL-23 and IL-1β drive the Th17 transcriptional program in human naive T cells and that this program is largely suppressed by CD28 signaling.…”